2013
DOI: 10.1152/ajpendo.00589.2012
|View full text |Cite
|
Sign up to set email alerts
|

TWEAK prevents TNF-α-induced insulin resistance through PP2A activation in human adipocytes

Abstract: Vázquez-Carballo A, Ceperuelo-Mallafré V, Chacón MR, Maymó-Masip E, Lorenzo M, Porras A, Vendrell J, Fernández-Veledo S. TWEAK prevents TNF-␣-induced insulin resistance through PP2A activation in human adipocytes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 23 publications
(23 citation statements)
references
References 54 publications
0
23
0
Order By: Relevance
“…For the JNK pathway, Ser/Thr phosphatases may act as negative regulators, but little is known about those phosphatases specifically targeting the upper tiers of MAP3K or MAP2K enzymes. The PP5 and PP2A-type phosphatases, known as ERK MAPK pathway regulators, are potential candidates for this role (48,53,(63)(64)(65)(66)(67)(68). For JNKs themselves, dual Thr and Tyr phosphorylation within the JNK activation loop TPY motif is required for full JNK activity; thus, the removal of either phosphate can decrease JNK activity toward all substrates.…”
Section: Phosphatases and Feedback Mechanisms In Control Of Jnk Activitymentioning
confidence: 99%
“…For the JNK pathway, Ser/Thr phosphatases may act as negative regulators, but little is known about those phosphatases specifically targeting the upper tiers of MAP3K or MAP2K enzymes. The PP5 and PP2A-type phosphatases, known as ERK MAPK pathway regulators, are potential candidates for this role (48,53,(63)(64)(65)(66)(67)(68). For JNKs themselves, dual Thr and Tyr phosphorylation within the JNK activation loop TPY motif is required for full JNK activity; thus, the removal of either phosphate can decrease JNK activity toward all substrates.…”
Section: Phosphatases and Feedback Mechanisms In Control Of Jnk Activitymentioning
confidence: 99%
“…(85). In both human and murine adipocytes, signaling through TNFR1 appears to have the largest contribution to insulin resistance (55,90). Adipose tissue macrophages (ATMs) produce the majority of TNF␣ in adipose tissue (93).…”
Section: Tumor Necrosis Factor-␣-stimulated Lipolysismentioning
confidence: 99%
“…It is noteworthy that initial evidence supports not only inhibition of TWEAK/Fn14 as a potential therapeutic option, but also exogenous Fn14 stimulation, e.g., to protect neurons, to antagonize TNF-induced insulin resistance or to improve regeneration of β-cells or liver regeneration. [16][17][18][19] Based on the isolation of Fn14-specific camelid-derived antibodies, we describe here the development of chimeric mouse-human cross-reactive Fn14-specific IgG1 monoclonal antibodies (mAbs) that efficiently block TWEAK-induced Fn14 signaling. Like other Fn14-targeting antibodies, our novel llama antibodies convert into highly active Fn14 agonists upon oligomerization or Fcγ receptor (FcγR) binding.…”
Section: A Novel Llama Antibody Targeting Fn14 Exhibits Anti-metastatmentioning
confidence: 99%